LBA-5 Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer (mCRC): the phase 3 LEAP-017 study
Titel:
LBA-5 Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer (mCRC): the phase 3 LEAP-017 study
Auteur:
Kawazoe, A. Xu, R. Passhak, M. Teng, H. Shergill, A. Gumus, M. Qvortrup, C. Stintzing, S. Towns, K. Kim, T. Shiu, K. Cundom, J. Ananda, S. Lebedinets, A. Fu, R. Jain, R. Adelberg, D. Heinemann, V. Yoshino, T. Élez, E.